These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 11122063

  • 1. Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis.
    Bañuls J, Ramón R, Pascual E, Navas J, Betlloch I, Botella R.
    Br J Dermatol; 2000 Dec; 143(6):1345. PubMed ID: 11122063
    [No Abstract] [Full Text] [Related]

  • 2. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
    Zahid MA, Klotz SA, Goldstein E, Bartholomew W.
    Clin Infect Dis; 1994 Jun; 18(6):999-1001. PubMed ID: 8086568
    [Abstract] [Full Text] [Related]

  • 3. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
    Tebas P, Sultan F, Wallace RJ, Fraser V.
    Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY, Joo MJ, Hose S, Sinha D, Dick JD, O'Brien TP.
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
    Parize P, Hamelin A, Veziris N, Morand PC, Guillemain R, Lortholary O, Dupin N.
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):101-5. PubMed ID: 25677464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cutaneous Mycobacterium chelonae infection presenting as symmetrical plaques on both shins in an immunocompetent patient.
    Chung WK, Kim MS, Kim CH, Lee MW, Choi JH, Moon KC, Koh JK.
    Acta Derm Venereol; 2009 Nov; 89(6):663-4. PubMed ID: 19997711
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin.
    Franck N, Cabié A, Villette B, Amor B, Lessana-Leibowitch M, Escande JP.
    J Am Acad Dermatol; 1993 Jun; 28(6):1019-21. PubMed ID: 8496448
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mycobacterium chelonae skin infection in kidney-pancreas recipient.
    Stelzmueller I, Dunst KM, Wiesmayr S, Zangerie R, Hengster P, Bonatti H.
    Emerg Infect Dis; 2005 Feb; 11(2):352-4. PubMed ID: 15759344
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.